Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kaplan

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
BMC Infectious Diseases|November 21, 2015
The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort studyMweete D Nglazi, Linda-Gail Bekker, Robin Wood, et al.
Clinical Medicine (London, England)|October 30, 2012
The Royal College of Physicians Simms Lecture, 6 December 2011: clinical research networks and the benefits of intensive healthcare systemsPeter Selby, Richard Kaplan, David Cameron, et al.
Tropical Medicine & International Health : TM & IH|May 6, 2009
The impact of gender and income on survival and retention in a South African antiretroviral therapy programmeMorna Cornell, Landon Myer, Richard Kaplan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2014
Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011)Richard Kaplan, Judy Caldwell, Keren Middelkoop, et al.
AIDS (London, England)|August 2, 2008
Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatmentRichard Kaplan, Catherine Orrell, Eugene Zwane, et al.
Tropical Medicine & International Health : TM & IH|December 3, 2014
Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South AfricaMonika Kamkuemah, Richard Kaplan, Linda-Gail Bekker, et al.
Plos One|April 6, 2012
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the communityAnkur Gupta, Robin Wood, Richard Kaplan, et al.
Lancet (London, England)|July 27, 2017
Diagnostic accuracy of the PROMIS study - Authors' replyHashim U Ahmed, Louise C Brown, Richard Kaplan, et al.
Plos One|February 19, 2013
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South AfricaAnkur Gupta, Robin Wood, Richard Kaplan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Chemotherapy-free intervals for patients with metastatic colorectal cancer remain an optionTim Maughan, Richard Adams, Richard Wilson, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
BMC Infectious Diseases|November 21, 2015
The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort studyMweete D Nglazi, Linda-Gail Bekker, Robin Wood, et al.
Clinical Medicine (London, England)|October 30, 2012
The Royal College of Physicians Simms Lecture, 6 December 2011: clinical research networks and the benefits of intensive healthcare systemsPeter Selby, Richard Kaplan, David Cameron, et al.
Tropical Medicine & International Health : TM & IH|May 6, 2009
The impact of gender and income on survival and retention in a South African antiretroviral therapy programmeMorna Cornell, Landon Myer, Richard Kaplan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2014
Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011)Richard Kaplan, Judy Caldwell, Keren Middelkoop, et al.
AIDS (London, England)|August 2, 2008
Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatmentRichard Kaplan, Catherine Orrell, Eugene Zwane, et al.
Tropical Medicine & International Health : TM & IH|December 3, 2014
Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South AfricaMonika Kamkuemah, Richard Kaplan, Linda-Gail Bekker, et al.
Plos One|April 6, 2012
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the communityAnkur Gupta, Robin Wood, Richard Kaplan, et al.
Lancet (London, England)|July 27, 2017
Diagnostic accuracy of the PROMIS study - Authors' replyHashim U Ahmed, Louise C Brown, Richard Kaplan, et al.
Plos One|February 19, 2013
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South AfricaAnkur Gupta, Robin Wood, Richard Kaplan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Chemotherapy-free intervals for patients with metastatic colorectal cancer remain an optionTim Maughan, Richard Adams, Richard Wilson, et al.
Pageof 15